100 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6826

Shanghai Haohai Biological Technology
HK$38.00-0.8%-5.6%HK$14.9bHK$70.01PE14.1xn/a2.8%

3737

Zhongzhi Pharmaceutical Holdings
HK$1.224.3%1.7%HK$1.1bn/aPE6xn/a4.9%

1548

Genscript Biotech
HK$11.02-9.4%-49.3%HK$23.4bHK$28.84PS3.6xE89.5%0%

2348

Dawnrays Pharmaceutical (Holdings)
HK$1.16-1.7%-14.7%HK$1.7bn/aPE4.9xn/a6.9%

2552

Hua Medicine (Shanghai)
HK$1.593.9%-50.3%HK$1.6bHK$3.29PS18.8xE83.3%n/a

8049

Jilin Province Huinan Changlong Bio-pharmacy
HK$1.80-0.6%11.1%HK$1.0bn/aPE6.3xn/a30.1%

1801

Innovent Biologics
HK$33.95-5.3%-13.1%HK$55.1bHK$55.73PS8.2xE50.8%n/a

570

China Traditional Chinese Medicine Holdings
HK$4.330.2%1.4%HK$21.8bHK$4.70PE15.7xE12.3%0%

2696

Shanghai Henlius Biotech
HK$15.263.5%2.8%HK$8.3bHK$17.78PE14xE15.9%n/a

1952

Everest Medicines
HK$23.35-1.9%56.1%HK$7.5bHK$28.05PS54.8xE80.2%n/a

1889

Sanai Health Industry Group
HK$0.033.4%-62.5%HK$96.3mn/aPE4.8xn/a0%

1177

Sino Biopharmaceutical
HK$2.54-5.2%-42.5%HK$46.6bHK$4.67PE23.3xE15.5%2.0%

1558

YiChang HEC ChangJiang Pharmaceutical
HK$11.96-6.0%67.0%HK$10.5bHK$14.00PE4.9xS2.2%0%

1643

Modern Chinese Medicine Group
HK$0.32-1.6%-35.1%HK$189.0mn/aPE3.6xn/a0%

460

Sihuan Pharmaceutical Holdings Group
HK$0.51-1.9%-37.0%HK$4.7bn/aPS2.4xE117.7%0%

2315

Biocytogen Pharmaceuticals (Beijing)
HK$7.8017.1%-68.7%HK$3.1bHK$15.39PS4xE100.1%n/a

1877

Shanghai Junshi Biosciences
HK$9.29-9.8%-71.0%HK$22.6bHK$24.35PS5.6xE41.3%n/a

6185

CanSino Biologics
HK$17.500.6%-57.5%HK$8.2bHK$26.33PS11.2xE124.2%0%

2142

HBM Holdings
HK$1.08-6.9%-47.6%HK$791.3mn/aPE4.4xn/an/a

1477

Ocumension Therapeutics
HK$5.840%-36.2%HK$4.1bHK$8.41PS15.2xE93.7%n/a

2186

Luye Pharma Group
HK$2.66-0.7%-32.0%HK$10.0bHK$3.01PE17.4xE28.7%0%

2256

Abbisko Cayman
HK$3.01-0.7%3.8%HK$1.8bHK$8.20PS85.4xE-2.3%n/a

2171

CARsgen Therapeutics Holdings
HK$4.52-5.0%-65.8%HK$2.6bHK$8.61PB1.3xE15.3%n/a

6990

Sichuan Kelun-Biotech Biopharmaceutical
HK$139.50-1.1%n/aHK$30.6bHK$182.81PS18.3xE22.9%n/a
Page 2 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.